Table 2 Risk of bias summary for each study included in the meta-analysis
From: Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis
Author | Year | Allocation concealment | Blinding | Intention to treat analysis | Loss to follow-up (%) | Early trial termination |
|---|---|---|---|---|---|---|
Akbulut | 2003 | Unclear | No | Yes | 0.0 | No |
Boccanelli | 2009 | Yes | Yes | Yes | 6.2 | No |
Chan | 2007 | Unclear | Yes | Yes | 0.0 | No |
Cicoira | 2002 | Unclear | Yes | Yes | 6.6 | No |
Deswal | 2011 | Yes | Yes | No | 4.3 | No |
Edelmann | 2013 | Yes | Yes | Yes | 1.2 | No |
Edwards | 2009 | Unclear | Yes | No | 2.7 | No |
Zannad | 2011 | Yes | Yes | Yes | 1.2 | Yes |
Pitt | 2003 | Yes | Yes | Yes | 0.3 | No |
Gao | 2007 | Yes | Yes | Yes | 0.0 | No |
Pitt | 2013 | No (open label Aldactone) | Yes | Yes | 0.0 | No |
Pitt | 1999 | Yes | Yes | Yes | 0.0 | Yes |
Pitt | 2014 | Yes | Yes | Yes | 3.8 | No |
Udelson | 2010 | Yes | Yes | Yes | 0.0 | No |
Vizzardi | 2014 | Yes | No | Yes | 0.0 | No |